Macromomycin B
|
| Names
|
Preferred IUPAC name
Methyl 7-methoxy-2-methylidene-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-5-carboxylate |
| Other names
Auromomycin
|
| Identifiers
|
|
|
|
|
|
|
| ChemSpider
|
|
|
|
|
| UNII
|
|
InChI=1S/C12H11NO5/c1-6-11(14)13-10-8(12(15)17-3)4-7(16-2)5-9(10)18-6/h4-5H,1H2,2-3H3,(H,13,14) Key: HXKWEZFTHHFQMB-UHFFFAOYSA-N InChI=1/C12H11NO5/c1-6-11(14)13-10-8(12(15)17-3)4-7(16-2)5-9(10)18-6/h4-5H,1H2,2-3H3,(H,13,14) Key: HXKWEZFTHHFQMB-UHFFFAOYAU
|
O=C(OC)c2cc(OC)cc1O/C(C(=O)Nc12)=C
|
| Properties
|
|
|
C12H11NO5
|
| Molar mass
|
249.219
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
| Infobox references
|
|
|
|
Tracking categories (test):
Macromomycin B is an antibiotic with anticancer activity.[1]
References
- ↑ Lippman, MM; Laster, WR; Abbott, BJ; Venditti, J; Baratta, M (April 1975). "Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.". Cancer Research 35 (4): 939–45. PMID 1116151.
 | Original source: https://en.wikipedia.org/wiki/Macromomycin B. Read more |
